Showing 1 - 10 of 21
Persistent link: https://www.econbiz.de/10003894044
Persistent link: https://www.econbiz.de/10003411356
Persistent link: https://www.econbiz.de/10003972551
Persistent link: https://www.econbiz.de/10010339707
Persistent link: https://www.econbiz.de/10009535811
Prescription opioid use among women of reproductive age and pregnant women is relatively common and growing prescription opioid use is associated with a commensurate increase in opioid use disorder (OUD) among pregnant women and neonatal abstinence syndrome (NAS) among infants. In this article,...
Persistent link: https://www.econbiz.de/10012841425
We examine whether obtaining prescription drug insurance through the Medicare Part D program affected hospital admissions, expenditures associated with those admissions, and mortality. We use a large, geographically diverse sample of Medicare beneficiaries and exploit the natural experiment of...
Persistent link: https://www.econbiz.de/10013057818
This article presents estimates of the effects of state prescription opioid policies on prescription opioid sales, mortality and socioeconomic outcomes of adults. Results indicate that state implementation of a “modern” PDMP is associated with decreases in opioid sales of between 5% and 20%...
Persistent link: https://www.econbiz.de/10013313249
Prescription opioid use among women of reproductive age and pregnant women is relatively common and growing prescription opioid use is associated with a commensurate increase in opioid use disorder (OUD) among pregnant women and neonatal abstinence syndrome (NAS) among infants. In this article,...
Persistent link: https://www.econbiz.de/10012479273
This article presents estimates of the effects of state prescription opioid policies on prescription opioid sales, mortality and socioeconomic outcomes of adults. Our analysis highlights that most prescription opioid use is medically prescribed and that curtailing such use may have adverse...
Persistent link: https://www.econbiz.de/10012480081